GHP Q4 2019

2 GHP / Q4 2019 Editor’s Note , Welcome to the Q4 issue of Global Health & Pharma Magazine - your source for the latest news and features from across the healthcare and pharmaceutical industries. Another year done. There’s something about breaking down the year into quarterly Editor’s letters that is quite surreal. It feels like a matter of a couple of months since I was writing about new beginnings and spring. Now, the nights draw in and the winter solstice is almost upon us. Shortly after that, we’re in a new decade. It’s all moving rather quickly. However, for now, let’s keep our eyes firmly on the present and this issue of GHP. Our cover spotlight for this quarter is Medd, a specialised architecture and design company that focuses on the specific needs of the healthcare market. We spoke with Medd’s CEO, Miguel Moura Castro, who discussed the importance of keeping the patient in mind at all times and working to ensure that all spaces consider wellbeing and wellness: “It’s important to consider and think about those who will use the space every day and what they need the space to achieve.” Elsewhere, we profile a leading non-surgical aesthetic treatment clinic, and a software compliance company that operates within the life science sector. Read inside to find out more. Other than that, GHP Magazine hopes you have a fantastic rest of the year ahead, and a wonderful start to 2020. See you all next year! Laura Brookes, Editor Phone: +44 (0) 203 970 0082 Email: l.brooke [email protected] Website: AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.